Medical research studies are an important part of the medical field. Medical research studies help medical professionals to determine what course of treatment works, what doesn’t, and what we should be looking into to make the next breakthrough. Part of medical research studies involves clinical trials with consenting participants who willingly take a drug and are monitored in order to gauge how well the drug works as well as any negative side affects that may occur. Consent to a trial for clinical drug development is highly important, and the continuing informed consent of all clinical trial participants is so protected and valued that it has its own section in the ninth revision of the American Psychological Association’s Ethical Code.
Clinical drug development. The word conjures to mind scientists in white lab coats and thick gloves going to work on pieces of equipment, possibly microscopes and vials full of gas, in order to create the next life-saving drug for the American population. These scientists are seen as men, though they can also be women. And they are here to save us,
America has a great deal of health problems. There is obesity and obesity-related illnesses which kill millions of people each year. There is cancer, which also kills millions, and heart disease, which kills millions. Generally in the top ten causes of deaths in the United States, a majority are preventable deaths.
We, as Americans, are struggling with our health.
Clinical drug development is important, in that it reduces symptoms or
Clinical drug development and trials are an extremely important part of the pharmaceutical industry, and allows scientists to test potential new drugs, treatments, surgical procedures, and devices. According to ClinicalTrials.gov, as of December 2016 there are 231,976 completed or in progress registered clinical trials, including 84,716 (37% of total) in the United States, and 47% in 194 foreign countries. And the number of trials continues to rise as medical studies continue to advance.
Every drug and treatment on the market has begun as a phase 1 clinical trial. Without these trials, we would not have discovered necessary vaccines that have nearly eliminated some previously lethal diseases, or developed technologies